GSTM1 and anemia: The main treatment for anemia consists of RBC transfusions: approximately a quarter of patients with MF are transfusion-dependent at diagnosis (when dependency is defined as the administration of >6 units of RBC over a period of 12 weeks for Hb levels <8.5 g/dl), and many more become so during the course of their illness (55).